PAR 4.65% 22.5¢ paradigm biopharmaceuticals limited..

Ann: IND QUESTIONS RECEIVED FROM US FDA, page-290

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,150 Posts.
    lightbulb Created with Sketch. 581
    Maybe Mr. Market is starting not to listen.

    In relation to the IND submission, PR stated "Do it right, get it right the first time" to explain away the length of time to drop the IND - and look where we are - over a 3 month delay.

    Can't wait for the 3-4 peer reviewed publications to drop - but we've been waiting for 2 years.

    TGA provisional approval.....In the interview with Capital 51, PR said the TGA informed them that there are existing therapies that work as well for pain or function and that to prove a "serious therapeutic advance" they would have to show DMOA effect - so risk elevated.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.010(4.65%)
Mkt cap ! $78.73M
Open High Low Value Volume
22.0¢ 23.5¢ 21.5¢ $288.5K 1.279M

Buyers (Bids)

No. Vol. Price($)
6 130626 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 60000 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.